Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 20 tags : Cancer save search
Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer
Published: 2021-10-20 (Crawled : 21:00) - biospace.com/
RDUS | $17.45 -0.85% -0.86% 380K
|
Health Technology
|
| O: 36.48%
H: 9.0%
C: -14.74%
positive results cancer topline elacestrant phase 3 breast cancer trial elascestrant
BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference
Published: 2021-10-20 (Crawled : 20:00) - biospace.com/
BYSI | $1.805 2.56% 2.49% 37K
|
Health Technology
|
| O: 0.96%
H: 6.9%
C: -0.42%
cancer conference plinabulin
BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherapy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell Lung Cancer
Published: 2021-10-20 (Crawled : 14:00) - beyondspringpharma.com
BYSI | $1.805 2.56% 2.49% 37K
|
Health Technology
|
| O: 0.96%
H: 6.9%
C: -0.42%
treatment lung cancer positive therapy cancer conference plinabulin
Lixte Biotechnology to Discuss its Collaboration with Leading European Cancer Centers at the Benzinga Global Small Cap Conference on October 28
Published: 2021-10-20 (Crawled : 14:00) - globenewswire.com
LIXT | $3.3 4.68% 22K
|
Health Technology
|
| O: 0.52%
H: 1.56%
C: -5.73%
europe collaboration cancer biotech technology iot conference
Open-label study of COMP360 psilocybin therapy for depression in cancer patients demonstrates feasibility of simultaneous psilocybin administration in small groups
Published: 2021-10-20 (Crawled : 13:15) - globenewswire.com
CMPS | $8.78 5.53% 5.24% 530K
|
Health Technology
|
| O: 2.13%
H: 2.17%
C: 0.7%
therapy cancer depression comp360 psilocybin
In-Vitro Colorectal Cancer Screening Tests Market revenue to cross USD 1.12 Bn by 2027: Global Market Insights Inc.
Published: 2021-10-20 (Crawled : 12:00) - prnewswire.com
EXAS | $63.845 -2.3% -2.36% 3.5M
|
Health Technology
|
| O: 0.29%
H: 0.17%
C: -1.15%
OCX | $2.66 5.14% 4.89% 170K
|
Health Technology
|
| O: -0.31%
H: 6.21%
C: 3.73%
test cancer colorectal cancer in vitro
BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell Lung Cancer
Published: 2021-10-20 (Crawled : 12:00) - beyondspringpharma.com
BYSI | $1.805 2.56% 2.49% 37K
|
Health Technology
|
| O: 0.96%
H: 6.9%
C: -0.42%
treatment lung cancer positive cancer conference plinabulin
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.